<SEC-DOCUMENT>0001213900-22-049740-index.html : 20220819
<SEC-HEADER>0001213900-22-049740.hdr.sgml : 20220819
<ACCEPTANCE-DATETIME>20220819170122
ACCESSION NUMBER:		0001213900-22-049740
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20220819
DATE AS OF CHANGE:		20220819
EFFECTIVENESS DATE:		20220819

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Actinium Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001388320
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				880378336
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-266996
		FILM NUMBER:		221181489

	BUSINESS ADDRESS:	
		STREET 1:		275 MADISON AVENUE, 7TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10016
		BUSINESS PHONE:		646-677-3875

	MAIL ADDRESS:	
		STREET 1:		275 MADISON AVENUE, 7TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10016

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cactus Ventures, Inc.
		DATE OF NAME CHANGE:	20070130
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>ea156670-s8_actiniumpharma.htm
<DESCRIPTION>REGISTRATION STATEMENT
<TEXT>
Document 1 - file: ea156670-s8_actiniumpharma.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>ea156670ex5-1_actiniumpha.htm <DESCRIPTION>OPINION OF HAYNES AND BOONE, LLP. <TEXT> Document 2 - file: ea156670ex5-1_actiniumpha.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>3 <FILENAME>ea156670ex23-1_actiniumpha.htm <DESCRIPTION>CONSENT OF MARCUM LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. <TEXT> Document 3 - file: ea156670ex23-1_actiniumpha.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.4 <SEQUENCE>4 <FILENAME>ea156670ex99-4_actiniumpha.htm <DESCRIPTION>THIRD AMENDMENT TO THE ACTINIUM PHARMACEUTICALS, INC. 2019 STOCK PLAN <TEXT> Document 4 - file: ea156670ex99-4_actiniumpha.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-FILING FEES <SEQUENCE>5 <FILENAME>ea156670ex-fee_actiniumpha.htm <DESCRIPTION>FILING FEE TABLE <TEXT> Document 5 - file: ea156670ex-fee_actiniumpha.htm
</DOCUMENT> </SEC-DOCUMENT>